J Neurol Neurosurg Psychiatry
March 2008
Objective: To evaluate the significance of antigliadin antibodies (AGA) levels for spinocerebellar ataxia type 2.
Methods: We determined AGA levels in 64 patients with spinocerebellar ataxia type 2 and in 65 healthy matched controls. The clinical assessment was carried out using the International Cooperative Ataxia Rating Scale and CAG repeat number was assessed by PCR.